| Product Code: ETC6736428 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Angina Pectoris Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Angina Pectoris Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Angina Pectoris Drugs Market - Industry Life Cycle |
3.4 China Angina Pectoris Drugs Market - Porter's Five Forces |
3.5 China Angina Pectoris Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
4 China Angina Pectoris Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of angina pectoris in China due to lifestyle changes and aging population |
4.2.2 Rising awareness about cardiovascular diseases and their management leading to higher demand for angina pectoris drugs |
4.2.3 Technological advancements in drug development and treatment options for angina pectoris patients |
4.3 Market Restraints |
4.3.1 Strict regulations and approval processes by Chinese regulatory authorities for new angina pectoris drugs |
4.3.2 Competition from generic drug manufacturers impacting the pricing and market share of branded angina pectoris drugs |
4.3.3 Potential side effects and safety concerns associated with angina pectoris drugs affecting their adoption and market growth |
5 China Angina Pectoris Drugs Market Trends |
6 China Angina Pectoris Drugs Market, By Types |
6.1 China Angina Pectoris Drugs Market, By Therapeutic Class |
6.1.1 Overview and Analysis |
6.1.2 China Angina Pectoris Drugs Market Revenues & Volume, By Therapeutic Class, 2021- 2031F |
6.1.3 China Angina Pectoris Drugs Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.4 China Angina Pectoris Drugs Market Revenues & Volume, By Calcium Antagonists, 2021- 2031F |
6.1.5 China Angina Pectoris Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.1.6 China Angina Pectoris Drugs Market Revenues & Volume, By Anti-Platelets, 2021- 2031F |
6.1.7 China Angina Pectoris Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 China Angina Pectoris Drugs Market Import-Export Trade Statistics |
7.1 China Angina Pectoris Drugs Market Export to Major Countries |
7.2 China Angina Pectoris Drugs Market Imports from Major Countries |
8 China Angina Pectoris Drugs Market Key Performance Indicators |
8.1 Number of new cases of angina pectoris diagnosed annually in China |
8.2 Adoption rate of advanced angina pectoris drugs compared to traditional treatment methods |
8.3 Patient adherence rate to prescribed angina pectoris drug regimens |
8.4 Research and development investment in innovative angina pectoris drug therapies |
8.5 Number of cardiologists trained in the diagnosis and treatment of angina pectoris |
9 China Angina Pectoris Drugs Market - Opportunity Assessment |
9.1 China Angina Pectoris Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
10 China Angina Pectoris Drugs Market - Competitive Landscape |
10.1 China Angina Pectoris Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Angina Pectoris Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here